Jordan Rush, PharmD, MS, 340B ACE (Jordan.rush@unchealth.unc.edu) is the director of pharmacy for 340B Programs, Pharmacy Revenue Integrity, and Medication Assistance Program Services at UNC Health. Previously, she was the director of outpatient and retail pharmacy services, managing outpatient pharmacies, meds to beds programs, a medication history team, and a PGY1 community pharmacy residency site in collaboration with the UNC Eshelman School of Pharmacy.
Jordan earned her PharmD from MCPHS and an MS from the University of Wisconsin, where she also completed a combined PGY1/PGY2 health-system pharmacy administration residency. Before joining UNC, she was an outpatient pharmacy manager at Johns Hopkins Homecare Group.
Throughout her career, Jordan has been actively involved with ASHP, serving in the Section of Pharmacy Practice Leaders and various Section Advisory Groups (SAGs). She has held roles as co-chair and chair of the Value, Quality, and Compliance SAG and participated in the Educational Steering Committee. Jordan has led webinars promoting resident participation in ASHP and highlighted outpatient pharmacy's role in COVID-19 vaccine distribution. She has presented on topics such as controlled substance diversion, expanding meds to beds programs, and creating internship opportunities. In 2020, she received an ASHP Best Practice Award for improving patient care transitions through UNC Hospitals' partnership with CPESN.
As the outgoing director-at-large in the Section of Community Pharmacy Practitioners, Jordan has supported multiple SAGs, contributed to strategic initiatives, and co-authored the “ASHP Statement on the Community Pharmacist’s Role in the Care Continuum.”
I am thrilled to support the section and see numerous opportunities to optimize services, expand business, share best practices, develop resources, enhance community pharmacy residencies, and improve patient care. COVID-19 underscored the critical role our pharmacies play in providing patient access to healthcare, while also highlighting challenges such as burnout and ongoing issues with technician retention and recruitment.
Alongside these workforce obstacles, community pharmacy practice faces the need to advance clinical services, demonstrate value and outcomes, address declining reimbursement and vertical integration across the industry, navigate ongoing 340B restrictions, and manage rising inventory costs. We must transition reimbursement models away from dispensing and provide the C-suite with compelling evidence of the value our pharmacies contribute to care transitions across the continuum as we will see an increase in pharmacy deserts across the country over the next several years.
I am passionate about community pharmacy and can leverage my enthusiasm, leadership skills, and prior experience as the Director-At-Large of this Section to continue to grow our membership and networking opportunities, provide tools and resources to expand services and recruit residents, and support members through these challenges. I am truly honored by this nomination to serve as chair elect and am committed to advancing the mission of our section.